• Free Investing e-Course
  • About
  • Advertise
  • Contact
  • Submit a Sponsored Post
Money Works Magazine
  • Life Sciences
  • Online Gaming
  • Real Estate
  • Download App
  • MORE
    • Technology
    • Personal Finance
    • Mining
DOWNLOAD YOUR COPY OF INVESTING IS FOR EVERYONE >
Money Works Magazine
  • Life Sciences
  • Online Gaming
  • Real Estate
  • Download App
  • MORE
    • Technology
    • Personal Finance
    • Mining
Money Works Magazine
Home Life Sciences

Canadian marijuana shortage dampens Aurora Cannabis’ international sales

Money Works Magazine by Money Works Magazine
May 22, 2019
in Life Sciences
0
Canadian marijuana shortage dampens Aurora Cannabis’ international sales
Share on FacebookShare on Twitter


A shortfall of cannabis in Canada’s regulated market took a toll on the international sales of an industry leader, Aurora Cannabis, according to the company.

The Alberta firm’s international medical cannabis sales rose nearly 40% to 4 million Canadian dollars ($3 million) in the third quarter, up from CA$2.9 million.

“While we continue to expand our business into international markets, we have faced supply shortages for export,” the company noted in a recent regulatory filing.

The company expects that shortage to abate in the coming quarters, as more production comes online and more facilities receive EU-Good Manufacturing Practices (EU-GMP) certification.

Only medical cannabis from facilities certified EU-GMP, or the equivalent, can be sold in key markets such as Germany.

Potential sales of medical cannabis in other countries – especially in Europe – underpin valuations for many Canadian marijuana companies.

The company’s massive Aurora Sky greenhouse is now fully licensed by Health Canada for the cultivation and sale.

That’s going to help Aurora meet demand for medical cannabis at home and overseas.

Aurora produced 15,590 kilograms (34,370 pounds) of marijuana in the latest quarter, doubling the previous period’s 7,822 kilograms.

“Based on the current production run rate, Aurora will have in excess of 25,000 kilograms of product harvested and dried during Q4 2019,” the company anticipates.

A subsidiary of Aurora was selected by German regulators to cultivate and distribute medical cannabis.

The company was awarded a maximum number of five of Germany’s 13 “lots” in the tender over a four-year period, “with a minimum supply of 4,000 kilograms in total. The cannabis produced will be sold to the German government and supplied to wholesalers for distribution to pharmacies,” according to Aurora.

Aurora was expecting the first “saleable” harvest from its Nordic 1 facility in Denmark by the end of March, with products available for sale expected by June.

Matt Lamers can be reached at [email protected]



Source link

Recommended

DocuSign Earnings: DOCU Stock Plummeted Despite Topping Q1 Guidance DocuSign Earnings: DOCU Stock Plummeted Despite Topping Q1 Guidance

DOCU Stock: Docusign Stock Takes a Bath on Earnings. Now What?

2 years ago
Back-to-School on a Budget – MintLife Blog

Back-to-School on a Budget – MintLife Blog

2 years ago
Facebook Twitter LinkedIn

MWM is your friendly source of knowledge on financial freedom via investment opportunities and financial planning to make your money work for you.

  • Submit a Sponsored Post
  • Contact
  • Privacy Policy

Get the latest financial tips and news.
Sign up today.

  • This field is for validation purposes and should be left unchanged.

© 2019 Money Works Magazine . All rights reserved.

  • Home
  • Life Sciences
  • Personal Finance
  • Online Gaming
  • Mining
  • Technology
  • How To Trade
  • Free e-Course
  • Money Works Magazine App

© 2019 Money Works Magazine . All rights reserved.